natgillin/translations-raw huggingface dataset:
NeuroBloc reduces the release of the ‘ chemical messenger’, acetylcholine, which is made by nerves and tells your muscles to contract.
NeuroBloc zavira sproščanje ‘ kemijskega sporočevalca ’ acetilholina, ki ga izločajo živci in mišicam dajejo ukaz za krčenje.
If nerves are prevented from releasing this messenger, abnormal muscle contractions may be reduced or completely stopped.
Če živcem preprečimo izločanje tega sporočevalca, lahko zmanjšamo ali celo povsem preprečimo nenormalno krčenje mišic.
NeuroBloc is used to treat cervical dystonia (torticollis).
NeuroBloc se uporablja za zdravljenje cervikalne distonije (tortikolisa).
If you have cervical dystonia, you experience contractions of the neck and/ or shoulder muscles that you cannot control.
Ob cervikalni distoniji imate krče mišic vratu in/ ali ramen, ki jih ne morete nadzorovati.
BEFORE YOU ARE GIVEN NEUROBLOC
KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ZDRAVILO NEUROBLOC
You should not receive / be given NeuroBloc:
Ne uporabljajte/ jemljite zdravila NeuroBloc:
- if you are allergic to any of the ingredients in this medicine
- če ste alergični na katerokoli sestavino zdravila
- if you suffer from a disease of the nerves or muscles especially one causing muscle weakness
- če imate obolenje živcev ali mišic, zlasti tako, ki povzroča šibkost mišic
- if you are pregnant or breast-feeding
- če ste noseči ali če dojite
In these cases, please tell your doctor.
V teh primerih povejte svojemu zdravniku.
Take special care with NeuroBloc and tell you doctor:
Bodite posebno pozorni pri uporabi zdravila NeuroBloc in zdravniku povejte tudi:
- if you suffer from a bleeding disorder such as haemophilia
- če imate motnje krvavenja, kot je hemofilija,
- when you are receiving medication such as warfarin, to prevent your blood clotting.
- če prejemate zdravilo za preprečevanje strjevanja krvi, kot je varfarin,
- if you have lung problems
- če imate težave s pljuči
- if you have any difficulty swallowing before or after your NeuroBloc injection.
- če imate težave pri požiranju pred ali po injiciranju NeuroBloca.
Rarely severe
Redko je lahko posledica
swallowing problems can result in breathing food or liquids into your lungs and cause pneumonia which might be fatal.
resnih težav s požiranjem vdihovanje hrane ali tekočin v pljuča, kar lahko povzroči pljučnico, ki je lahko tudi usodna.
NeuroBloc is not approved for use in children.
Otroci ne smejo jemati NeuroBloca.
You should not normally be given NeuroBloc if you are under 18 years old.
Če ste mlajši od 18 let, vam na splošno NeuroBloca ne bi smeli dati.
26 Please tell your doctor if you are taking antibiotics for an infection.
Uporaba drugih zdravil Obvestite svojega zdravnika, če jemljete antibiotike proti okužbi.
If you are going to have an operation, please tell your doctor if you have been given NeuroBloc as it can interfere with medicines you may be given before a general anaesthetic.
Pred kirurškim posegom povejte zdravniku, da so vam dali NeuroBloc, ker lahko ovira delovanje zdravil, ki vam jih bodo morda dali pred splošno anestezijo.
Also inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even those not prescribed.
25 Obvestite svojega zdravnika ali farmacevta tudi, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
Pregnancy and breast feeding Generally, you should not be given NeuroBloc if you are pregnant or breast-feeding, this is because there is not enough information about the use of NeuroBloc in patients who are pregnant and it is not known if breast milk contains NeuroBloc in nursing mothers treated with the medicine.
Nosečnost in dojenje Na splošno vam ne bi smeli dati NeuroBloca, če ste noseči ali če dojite, saj ni dovolj informacij o uporabi zdravila NeuroBloc pri nosečih bolnicah in ni znano, ali mleko zdravljenih doječih mater vsebuje zdravilo NeuroBloc.
Ask your doctor or pharmacist for advice before taking any medicine.
Pred uporabo kateregakoli zdravila se posvetujte z zdravnikom.
Driving and using machines If you feel tired, have any loss of sensation or blurred vision take care when driving or operating machinery.
Vpliv na sposobnost upravljanja vozil in strojev Če ste utrujeni, postajate manj pozorni ali imate zamegljen vid, pazite, kadar vozite ali upravljate s stroji.
Important information about some of the ingredients of NeuroBloc The medicinal product contains less than 1 mmol sodium (23 mg) per 10,000 units of NeuroBloc, i. e. essentially “ sodium free”.
Pomembne informacije o nekaterih sestavinah NeuroBloca Zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na 10. 000 enot zdravila NeuroBloc, tj. v bistvu je „ brez natrija “.
HOW YOU WILL BE GIVEN NEUROBLOC
KAKO UPORABLJATI ZDRAVILO NEUROBLOC
Your doctor will decide how much NeuroBloc to give you.
Zdravnik se bo odločil, koliko NeuroBloca vam bo dal.
The dose will usually be 10,000 Units, but it can be higher or lower, depending on your doctor’ s decision and your response to any previous injections of NeuroBloc.
Običajni odmerek je 10. 000 enot, vendar je lahko tudi večji ali manjši, glede na zdravnikovo odločitev in vaš odziv na predhodno injiciranje NeuroBloca.
If you have the impression that the effect of NeuroBloc is too strong or too weak, talk to your doctor.
Če menite, da je učinek NeuroBloca premočan ali prešibak, se posvetujte z zdravnikom.
NeuroBloc will be injected into your neck and/ or shoulder muscles, depending on which ones are causing the problem.
NeuroBloc vam bodo injicirali v mišice vratu in/ ali ramen, odvisno od tega, katere vam povzročajo težave.
Your doctor will decide into which muscles to inject NeuroBloc and may inject part of the dose into different places in the muscles.
Zdravnik se bo odločil, v katere mišice vam bo injiciral NeuroBloc, in morda bo del odmerka injiciral v različna mesta v teh mišicah.
The effects of NeuroBloc will usually wear off after approximately 12 to 16 weeks.
Učinek NeuroBloca bo običajno izginil po približno 12 do 16 tednih.
Your doctor will decide when you need another injection and how much to give you.
Zdravnik se bo odločil, kdaj potrebujete naslednjo injekcijo in kolikšen odmerek vam bo dal.
You can continue injections of NeuroBloc as long as it gives you relief from your symptoms.
NeuroBloc vam lahko injicirajo toliko časa, dokler vam blaži bolezenske znake.
After you have had a number of injections, your body may produce antibodies that may make the treatment less effective.
Potem ko prejmete več injekcij, lahko vaše telo proizvede protitelesa, zaradi katerih je zdravljenje manj učinkovito.
Your doctor knows about this and will look for signs of it.
Zdravnik to ve in bo pozoren na znake tega pojava.
If you are given more NeuroBloc than you need, some of your muscles that were not injected may feel weak.
Če prejmete več NeuroBloca, kot ga potrebujete, bodo morda šibke tudi nekatere mišice, v katere vam zdravila niso injicirali.
If this happens you should speak to your doctor immediately.
Če to opazite, nemudoma povejte zdravniku.
Tell your doctor immediately if you have difficulty breathing.
Nemudoma mu tudi povejte, če imate težave pri dihanju.
If he/ she is unavailable seek emergency assistance.
Če je nedosegljiv( a), poiščite nujno pomoč.
If you forget to visit your doctor to receive your injection The effects of NeuroBloc will gradually wear off and the abnormal muscle contractions may come back.
Če pozabite obiskati zdravnika, da bi prejeli injekcijo Učinek NeuroBloca bo postopoma izginil in nenormalno krčenje mišic se lahko povrne.
Like all medicines, NeuroBloc can cause side effects, although not everybody gets them.
Kot vsa zdravila lahko tudi zdravilo NeuroBloc povzroči neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
You may feel pain at the place where you had the injection but this should wear off after a few minutes.
Morda boste čutili bolečino na mestu injiciranja, vendar bi ta po nekaj minutah morala prenehati.
27 Effects may be seen in other areas than where you have received the injection and may occur days to weeks after injection.
Učinki se lahko pojavijo drugje kot na mestu, kjer je bilo injicirano zdravilo več dni ali tednov po injiciranju.
You may find that your mouth feels dry and/ or that swallowing becomes difficult.
Morda boste imeli občutek suhih ust in/ ali težave pri požiranju ali kratko sapo.
In rare cases difficulty in swallowing may be severe and choking is possible.
V redkih primerih so težave s požiranjem hude in možno je dušenje.
If you develop new or worsening swallowing difficulty, choking or breathing problems seek medical help immediately.
Če se pojavijo nove težave s požiranjem ali se obstoječe poslabšajo, če se dušite ali imate težave z dihanjem, se posvetujte s svojim zdravnikom.
You may also notice one or more of the following effects after injection:
26 Po injiciranju boste morda opazili enega ali več izmed naslednjih neželenih učinkov:
Very common reported side effects (likely to occur in more than 1 in 10 patients)
Zelo pogosto poročani neželeni učinki (verjetno se bodo pojavili pri več kot 1 od 10 bolnikov)
- Dry mouth
- suha usta
- Difficulty swallowing
- težave s požiranjem
- Headache
-
Common reported side effects (likely to occur in fewer than 1 in 10 patients). weakness, pain or muscle stiffness around your body
Pogosto poročani neželeni učinki (verjetno se bodo pojavili pri manj kot 1 od 10 bolnikov)
- neck pain
- bolečine v vratu,
- indigestion
- slabo prebavo,
- changes in the taste of your food and drink
- spremenjeno okušanje hrane in pijače,
- changes in the sound of your voice.
- spremembe zvoka glasu,
- blurred vision
- zamegljen vid,
- drooping of the upper eyelid
- povešena zgornje veke.
- flu-like symptoms
- znaki, podobni kot pri gripi,
- loss of strength or energy
- pomanjkanje moči ali energije.
It is also possible that torticollis (turning of your head which you cannot control) could become worse after you have had your injection.
Lahko se tudi zgodi, da se po injekciji poslabša vaš tortikolis (nenadzorovano obračanje glave).
If any of the side effects get serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta..
HOW TO STORE NEUROBLOC
SHRANJEVANJE ZDRAVILA NEUROBLOC
Do not use after the expiry date stated on the carton.
Zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini.
Store in a refrigerator (2°C-8°C).
Shranjujte v hladilniku (2 °C - 8 °C)..
The date at which the product was taken out of the refrigerator should be mentioned on the outer carton.
Datum, ko ste zdravilo vzeli iz hladilnika, zabeležite na ovojnini.
Due to the special nature of NeuroBloc, used vials, needles and syringes must be processed as Medical Biohazardous Waste in accordance with local requirements.
Zaradi posebne narave zdravila NeuroBloc je treba rabljene viale, igle in brizge obravnavati kot medicinske biološko nevarne odpadke v skladu z lokalnimi zahtevami.
What NeuroBloc contains
En ml vsebuje 5. 000 e botulinskega toksina
One ml contains 5000 U Botulinum Toxin Type B.
vrste B.
- The other ingredients are disodium succinate, sodium chloride, human serum albumin (containing
- pomožne snovi so dinatrijev sukcinat, natrijev klorid, humani serumski albumin (vsebuje
sodium caprylate and sodium acetyltryptophanate as excipients), hydrochloric acid (for pH adjustment) and water for injections.
natrijev kaprilat in natrijev acetiltriptofanat kot vehikla), klorovodikova kislina (za uravnavanje pH) in voda za injekcije.
What NeuroBloc looks like and contents of the pack
27 Izgled zdravila NeuroBloc in vsebina pakiranja
NeuroBloc is a clear and colourless to pale yellow solution supplied in a glass vial that contains 0.5ml (2500Units), 1.0ml (5000 Units) or 2.0ml (10,000 Units) of solution for injection.
NeuroBloc je bistra, brezbarvna ali svetlo rumena raztopina, pakirana v stekleno vialo, ki vsebuje 0, 5ml (2. 500 enot), 1, 0 ml (5. 000 enot) ali 2, 0 ml (10. 000 enot) raztopine za injiciranje.
Marketing Authorisation holder:
Imetnik dovoljenja za promet z zdravilom
Eisai Limited Mosquito Way Hatfield Hertfordshire AL10 9SN United Kingdom
Eisai Limited Mosquito Way Hatfield Herts AL10 9SN Velika Britanija
Manufacturer
Izdelovalec je:
Eisai Manufacturing Limited Mosquito Way Hatfield Hertfordshire AL10 9SN United Kingdom
Eisai Manufacturing Limited Mosquito Way Hatfield Herts AL10 9SN Velika Britanija
Deutschland Eisai GmbH Tel: + 49 (0) 696 65 85-0
Deutschland Eisai GmbH, Tel: + 49 (0) 696 65 85- 0
Polska Eisai Ltd.
28 Polska Ελλάδα Eisai Ltd.
España Eisai Farmacéutica, S. A.
Portugal España EF- Eisai Farmacêutica, Eisai Farmacéutica, S. A.
Tel: +34 91 455 94 55
Unipessoal Lda Tel: + 34 91 455 94 55 Tel: + 351 21 421 7399
Tel: + 44 (0) 208 600 1400 United Kingdom
Ireland Eisai Ltd, Tel: + 44 (0) 208 600 1400 (United Kingdom)
31 ------------------------------------------------------------------------------------------------------------------------- The following information is intended for medical or healthcare professionals only
29 --------------------------------------------------------------------------------------------------------------------- Naslednje navodilo je namenjeno samo medicinskemu ali zdravstvenemu osebju:
INSTRUCTIONS FOR USE, HANDLING AND DISPOSAL
NAVODILA ZA PRIPRAVO IN RAVNANJE Z ZDRAVILOM IN ODLAGANJE
NeuroBloc is provided as a clear and colourless to light yellow sterile injectable solution in vials for single use only.
NeuroBlock je dobavljen kot bistra in brezbarvna ali svetlo rumena sterilna raztopina, pripravljena za injiciranje, v vialah za enkratno uporabo.
NeuroBloc may be diluted with sodium chloride 9 mg/ ml (0.9%) solution for injection.
NeuroBloc lahko razredčite z natrijevim kloridom 9 mg/ ml (0, 9%) raztopino za injiciranje.
Place the absorbed toxin in an autoclave bag, seal it and process as Medical Biohazardous Waste in accordance with local requirements.
Absorbirani toksin dajte v vrečko za avtoklav, zaprite in obdelajte kot medicinski biološko nevaren odpadek v skladu z lokalnimi predpisi.
What is NEVANAC?
Kaj je zdravilo NEVANAC?
NEVANAC is a yellow eye drop suspension that contains the active substance nepafenac.
Zdravilo NEVANAC je suspenzija kapljic za oko rumene barve, ki vsebuje zdravilno učinkovino nepafenak.
What is NEVANAC used for?
Za kaj se zdravilo NEVANAC uporablja?
NEVANAC is used to prevent and treat the pain and inflammation that can occur after an operation to remove a cataract from the eye.
Zdravilo NEVANAC se uporablja za preprečevanje in zdravljenje bolečin ter vnetij, ki se lahko pojavijo po operaciji odstranjevanja katarakte iz očesa.
How is NEVANAC used?
Kako se zdravilo NEVANAC uporablja?
The dose of NEVANAC is one drop into the affected eye(s) three times a day beginning one day before the cataract operation.
Odmerek zdravila NEVANAC je ena kapljica v prizadeto oko (prizadeti očesi) trikrat na dan, uporabljati pa se začne en dan pred operacijo katarakte.
Treatment is continued for two to three weeks after the operation.
Zdravljenje se nadaljuje dva ali tri tedne po operaciji.
An extra drop should be given 30 to 120 minutes before the operation begins.
Dodatno kapljico je treba dati 30 do 120 minut pred začetkom operacije.
If other eye medicines are also being used, there should be a gap of at least five minutes between using each medicine.
Če se uporabljajo tudi druga zdravila za oko, mora med uporabo posameznega zdravila preteči vsaj pet minut.
How does NEVANAC work?
Kako zdravilo NEVANAC deluje?
The active substance in NEVANAC, nepafenac, is a ‘ prodrug ’ of amfenac.
Zdravilna učinkovina zdravila NEVANAC je nepafenak, ki je „ predzdravilo “ amfenaka.
This means that it is converted into amfenac in the eye.
To pomeni, da se v očesu pretvori v amfenak.
It works by blocking an enzyme called cyclo-oxygenase, which produces prostaglandins, substances that are involved in the inflammation process.
Deluje tako, da zavre encim, imenovan ciklooksigenaza, ki tvori prostaglandine, snovi, vpletene v vnetni proces.
By reducing the production of prostaglandins in the eye, NEVANAC can reduce the inflammation and pain caused by eye surgery.
Z zmanjšanjem tvorjenja prostaglandinov v očesu lahko zdravilo NEVANAC zmanjša vnetje in bolečino, ki jo povzroči operacija očesa.
How has NEVANAC been studied?
Kako je bilo zdravilo NEVANAC raziskano?
The effects of NEVANAC were first tested in experimental models before being studied in humans.
Učinki zdravila NEVANAC so bili najprej preizkušeni na poskusnih modelov, nato pa so jih raziskali pri ljudeh.
The effectiveness of NEVANAC has been studied in four main studies involving a total of 1,201 patients undergoing cataract surgery.
Učinkovitost zdravila NEVANAC je bila raziskana v štirih glavnih študijah, ki so vključevale skupaj 1. 201 bolnikov z operacijo katarakte.
One study compared NEVANAC used once, twice or three times a day with placebo (dummy eye drops) in 220 patients.
V eni od študij so zdravilo NEVANAC, uporabljano enkrat, dvakrat ali trikrat na dan, primerjali s placebom (kapljicami za oko brez zdravilne učinkovine) pri 220 bolnikih.
The other three studies, in a total of 981 patients, compared NEVANAC used three times a day, either with placebo, with ketorolac eye drops (another NSAID) or with both placebo and ketorolac.
V ostalih treh študijah, ki so vključevale skupaj 981 bolnikov, so zdravilo NEVANAC, uporabljano trikrat na dan, primerjali s placebom, kapljicami za oko ketorolak (drugo zdravilo NSAID) ali s placebom in kapljicami ketorolak.
These were measured two weeks after surgery.
Glavno merilo učinkovitosti je bil delež bolnikov, pri katerih je bilo zdravljenje uspešno (bili so brez ali pa so imeli le malo znakov vnetja očesa), ali delež
(44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged What benefit has NEVANAC shown during the studies?
Znake so merili dva tedna po operaciji.
NEVANAC was more effective than placebo and as effective as ketorolac in reducing signs of inflammation.
Zdravilo NEVANAC je bilo pri zmanjšanju znakov vnetja učinkovitejše od placeba in enako učinkovito kot kapljice za oko ketorolak.
In the study comparing different doses, the patients using NEVANAC three times a day had the lowest failure rate.
V študiji, v kateri so primerjali različne odmerke, je bilo zdravljenje bolnikov, ki so uporabljali zdravilo NEVANAC trikrat dnevno, najuspešnejše.
When NEVANAC was compared with placebo, around 70% of the patients using NEVANAC had no signs of inflammation after two weeks, compared with 17% to 59% of those using placebo.
Ko so zdravilo NEVANAC primerjali s placebom, okoli 70% bolnikov, ki so uporabljali zdravilo NEVANAC, po dveh tednih ni imelo znakov vnetja, v primerjavi s 17% – 59% tistih, ki so uporabljali placebo.
In the study comparing NEVANAC with ketorolac, around 65% of both groups of patients showed no or few signs of inflammation.
V študiji, v kateri so zdravilo NEVANAC primerjali s kapljicami za oko ketorolak, približno 65% bolnikov iz obeh skupin ni imelo nobenih znakov vnetja ali pa je bilo teh znakov malo.
What is the risk associated with NEVANAC?
Kakšna tveganja so povezana z zdravilom NEVANAC?
The most common side effects with NEVANAC (seen in between 1 and 10 patients in 100) are headache, punctate keratitis (spots of inflammation in the cornea, the transparent layer in front of the pupil), eye pain, blurred vision, eye pruritis (itching), dry eye, a sensation of a foreign body in the eyes and crusting at the edge of the eyelid.
Najpogostejši neželeni učinki zdravila NEVANAC (opaženi pri 1 do 10 bolnikih od 100) so glavobol, pikčasti keratitis (vnetne pege v roženici, prozorni plasti očesa pred zenico), očesne bolečine, zamegljen vid, očesni pruritus (srbenje), suho oko, občutek tujka v očesu, kraste na robovih vek.
Similar side effects were seen in patients using placebo or ketorolac eye drops.
Podobne neželene učinke so opazili pri bolnikih, ki so uporabljali placebo ali kapljice za oko ketorolak.
For the full list of all side effects reported with NEVANAC, see the Package Leaflet.
Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila NEVANAC, glejte Navodilo za uporabo.
NEVANAC should not be used in people who may be hypersensitive (allergic) to nepafenac, to any of the other ingredients or to other NSAIDs.
Zdravila NEVANAC se ne smejo uporabljati pri osebah, ki utegnejo biti preobčutljive za (alergične na) nepafenak ali katerokoli drugo sestavino zdravila ali na druge NSAID.
Like other NSAIDs, NEVANAC should not be used in patients who have previously had an attack of asthma, hives or inflammation of the nasal passages when they take aspirin or other NSAIDs.
Kot drugih NSAID tudi zdravila NEVANAC ne smejo uporabljati bolniki, ki so ob zaužitju aspirina ali drugih NSAID že doživeli napad astme, dobili izpuščaje ali imeli vnetje nosne votline.
NEVANAC contains benzalkonium chloride, which is known to discolour soft contact lenses.
Zdravilo NEVANAC vsebuje benzalkonijev klorid, katerega znana lastnost je, da razbarva mehke kontaktne leče.
Why has NEVANAC been approved?
Zakaj je bilo zdravilo NEVANAC odobreno?
The Committee for Medicinal Products for Human Use (CHMP) decided that NEVANAC’ s benefits are greater than its risks for prevention and treatment of postoperative pain and inflammation associated with cataract surgery.
Odbor za zdravila za uporabo v humani medicini (CHMP) meni, da so koristi zdravila NEVANAC pri preprečevanju in zdravljenju pooperacijskih bolečin in vnetij, povezanih z operacijo katarakte, večje od z njim povezanih tveganj.
The Committee recommended that NEVANAC be given marketing authorisation.
Odbor je priporočil odobritev dovoljenja za promet z zdravilom NEVANAC.
Other information about NEVANAC:
Druge informacije o zdravilu NEVANAC:
The European Commission granted a marketing authorisation valid throughout the European Union for NEVANAC to Alcon Laboratories (UK) Ltd. on 11 December 2007.
Evropska komisija je dovoljenje za promet z zdravilom NEVANAC, veljavno po vsej Evropski uniji, odobrila družbi Alcon Laboratories (UK) Ltd. dne 11. decembra 2007.
The full EPAR for NEVANAC can be found here.
Celotno Evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo NEVANAC je na voljo tukaj.
Package size
plastenka
Bottle (LDPE)
okularna uporaba
NEVANAC 1 mg/ ml eye drops, suspension
NEVANAC 1 mg/ ml kapljice za oko, suspenzija
Excipients: benzalkonium chloride 0.05 mg.
Pomožne snovi: benzalkonijev klorid 0, 05 mg.
Eye drops, suspension (eye drops) Light yellow to dark yellow uniform suspension, pH 7.4 (approximately).
Kapljice za oko, suspenzija (kapljice za oko) Svetlo rumena do temno rumena enakomerna suspenzija, pH 7, 4 (približno).
Prevention and treatment of postoperative pain and inflammation associated with cataract surgery (see section 5.1).
Preprečevanje in zdravljenje pooperativne bolečine in vnetja po operaciji katarakte (glejte poglavje 5. 1).
Use in adults, including the elderly The dose is one drop of NEVANAC in the conjunctival sac of the affected eye(s) 3 times daily beginning 1 day prior to cataract surgery, continued on the day of surgery and for the first 2 weeks of the postoperative period.
Bolnik začne zdravilo uporabljati en dan pred operacijo katarakte in z njegovo uporabo nadaljuje na dan operacije in še 2 tedna v pooperativnem obdobju.
Treatment can be extended to the first 3 weeks of the postoperative period, as directed by the clinician.
Zdravljenje lahko traja do tri tedne po operaciji, po zdravnikovem navodilu.
An additional drop should be administered 30-120 minutes prior to surgery.
Od 30 do 120 minut pred kirurškim posegom je treba bolniku vkapati še dodatno kapljico.
Paediatric patients NEVANAC is not recommended for use in children below 18 years due to a lack of data on safety and efficacy.
Pediatrični bolniki Zdravilo NEVANAC ni priporočljivo za uporabo pri otrocih, mlajših od 18 let, ker ni podatkov o njegovi varnosti in učinkovitosti.